Open AccessEffects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL
Author(s) -
Christine P. Limonte,
Leila R. Zelnick,
Andrew N. Hoofnagle,
Ravi Thadhani,
Michal L. Melamed,
Samia Mora,
Nancy R. Cook,
Heike LuttmannGibson,
Howard D. Sesso,
I.-Min Lee,
Julie E. Buring,
Jo Ann E. Manson,
Ian de Boer
Publication year - 2022
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0006472022
Subject(s) - medicine , vitamin d and neurology , placebo , parathyroid hormone , vitamin , secondary hyperparathyroidism , renal function , endocrinology , cancer , vitamin d deficiency , gastroenterology , calcium , pathology , alternative medicine
Reduced 25-hydroxyvitamin D (25[OH]D) metabolism and secondary hyperparathyroidism are common with lower estimated glomerular filtration rate (eGFR) and may contribute to cardiovascular disease and cancer risk.